CLINICAL_TRIALS
trial_result
· 2017-04-21
Clinical Trial Update: A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris [Phase 2]
Summary
A Phase 2 psoriasis plaque test trial comparing LEO 90100 to Betesil in psoriasis vulgaris, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: LEO Pharma | Conditions: Skin and Connective Tissue Diseases | Phase 2 | Status: COMPLETED | Results posted: 2017-04-21